TCIM
MNTA

TIAA CREF Investment Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

TIAA CREF Investment Management’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$2.51M Sell
172,937
-86,927
-33% -$1.11M ﹤0.01% 1878
2018
Q4 		$2.87M Sell
259,864
-3,779
-1% -$52.6K ﹤0.01% 1737
2018
Q3 		$6.93M Sell
263,643
-13,093
-5% -$354K ﹤0.01% 1353
2018
Q2 		$5.66M Sell
276,736
-32,055
-10% -$688K ﹤0.01% 1513
2018
Q1 		$5.61M Buy
308,791
+1,069
+0.3% +$17.8K ﹤0.01% 1488
2017
Q4 		$4.29M Sell
307,722
-12,099
-4% -$164K ﹤0.01% 1706
2017
Q3 		$5.92M Sell
319,821
-65,365
-17% -$1.09M ﹤0.01% 1519
2017
Q2 		$6.51M Buy
385,186
+211,782
+122% +$3.22M ﹤0.01% 1418
2017
Q1 		$2.31M Sell
173,404
-11,915
-6% -$187K ﹤0.01% 2042
2016
Q4 		$2.79M Sell
185,319
-18,911
-9% -$250K ﹤0.01% 1992
2016
Q3 		$2.39K Sell
204,230
-5,878
-3% -$69.1K ﹤0.01% 2073
2016
Q2 		$2.27M Sell
210,108
-24,683
-11% -$255K ﹤0.01% 2036
2016
Q1 		$2.17M Hold
234,791
– – ﹤0.01% 2020
2015
Q4 		$3.48M Sell
234,791
-5,873
-2% -$98.3K ﹤0.01% 1806
2015
Q3 		$3.95M Buy
240,664
+14,186
+6% +$290K ﹤0.01% 1702
2015
Q2 		$5.17M Buy
226,478
+58,019
+34% +$1.16M ﹤0.01% 1660
2015
Q1 		$2.56M Sell
168,459
-4,074
-2% -$52.9K ﹤0.01% 2070
2014
Q4 		$2.08M Sell
172,533
-34,310
-17% -$392K ﹤0.01% 2200
2014
Q3 		$2.35M Sell
206,843
-66,597
-24% -$760K ﹤0.01% 2120
2014
Q2 		$3.3M Buy
273,440
+6,895
+3% +$81.4K ﹤0.01% 1972
2014
Q1 		$3.1M Sell
266,545
-4,570
-2% -$77.4K ﹤0.01% 1964
2013
Q4 		$4.79M Sell
271,115
-4,900
-2% -$82.3K ﹤0.01% 1662
2013
Q3 		$3.97M Sell
276,015
-5,787
-2% -$88.6K ﹤0.01% 1748
2013
Q2 		$4.24M Buy
+281,802
New +$3.72M ﹤0.01% 1645

Other funds holding MNTA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

TIAA CREF Investment Management's MNTA Position: Q1 2019 in Review

TIAA CREF Investment Management reduced its Momenta Pharmaceuticals, Inc. (MNTA) stake by 33% in Q1 2019, selling an estimated $1.11M and leaving 172,937 shares worth $2.51M. The position accounts for ﹤0.01% of the portfolio, ranked #1878.

TIAA CREF Investment Management first reported a position in MNTA in Q2 2013 and has held it in 24 quarters since. The position peaked at $6.93M in Q3 2018. 147 funds tracked by Wall St. Rank hold MNTA as of Q1 2019.

  • TIAA CREF Investment Management held 172,937 shares of Momenta Pharmaceuticals, Inc. worth $2.51M as of Q1 2019.
  • TIAA CREF Investment Management sold 86,927 Momenta Pharmaceuticals, Inc. shares in Q1 2019, an estimated $1.11M.
  • Momenta Pharmaceuticals, Inc. made up ﹤0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #1878 holding.
  • TIAA CREF Investment Management first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2013 and has held it in 24 quarters since.
  • TIAA CREF Investment Management's Momenta Pharmaceuticals, Inc. position peaked at $6.93M in Q3 2018.
  • 147 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.